This document summarizes the qualifications of Veljko Puskovic as a molecular biologist/neuroscientist. It includes his contact information, 15 years of experience in biotech and academia, and competencies in areas like molecular biology techniques, pain research, gene therapy, and project management. It then details his professional experience at companies like Galleon Pharmaceuticals and universities including Thomas Jefferson, Michigan, and Pittsburgh. His roles involved leading research initiatives, developing models, and publishing papers. The document demonstrates his extensive and diverse skillset for scientific research roles.

1. Veljko Puskovic
757 Oak View Rd  Ardmore PA 19003  (215) 906-7119  vpuskovic@hotmail.com
Molecular Biologist/Neuroscientist with broad skills developed over 15 years in biotech and academic
environments. Flexible team member with demonstrated ability to deliver quality results with limited
resources. Accountable professional who is trusted to assume additional business responsibilities.
Competencies include:
• Molecular Biology
techniques
• Pain • Gene Therapy • Outsourcing
• Electrophysiology • Breathing control • Cell culture • Project Management
• Immunology • Parkinson’s disease • InVivo • Small animal surgery
PROFESSIONAL EXPERIENCE
Galleon Pharmaceuticals, Horsham, Pennsylvania 2008-Present
Clinical stage biotech company working on novel breathing control medicines.
Research Scientist
Led a variety of lab and collaborative initiatives. Prepared and authored protocols, SOP’s, IND and IMPD
reports for pain and breathing control compounds. Participated in the Clinical Advisory Board and partnership
meetings. Functioned as Outsourcing Manager.
• Innovations included developing pain group from ground up, validation of several pain models, and the
development of multiple breathing control models.
• Identified drug discovery platform that resulted in successful completion of clinical development
candidate package.
• Established contact and relations with key opinion leaders (KOL’s).
• Presented at national and international conferences and prepared manuscripts for publication.
• Identified clinical leads and progressed them through IND application.
• Outsourced studies to external CRO's, including:
a) Obtaining quotes and negotiating total cost of the study.
b) Study design and protocol review.
c) Tracking budgets and study progress.
Thomas Jefferson University, Philadelphia, Pennsylvania 2006 to 2008
Department of Neurology, Abdolmohamad Rostami M.D., Principal Investigator
Research Technician C
Designed and executed research projects; analyzed data for manuscripts and grants; conducted literature
searches; wrote manuscripts, protocols and presentations.
• Worked on role and characterization of CD8 T-cells, in EAE model of Multiple Sclerosis.
• Collaborated with a group of scientist to help solve clinical research problems.
• Presented findings in scientific meetings and conferences.

2. Veljko Puskovic Page 4
(215) 906-7119  vpuskovic@hotmail.com
University of Michigan, Ann Arbor, Michigan 2004 to 2006
Department of Neurology, David Fink, MD. & Marina Mata, MD., Principal Investigators
Research Associate IV
Worked on independent projects with expectations for publications. Tested therapeutic drugs for pharmaceutical
companies. Collaborated with scientists to help solve clinical research problems.
• Responsible for advancing Parkinson’s disease and pain projects.
• Developed procedures and new techniques.
• Supervised and trained work-study students in daily operations of research study. Trained and provided
ongoing support for research staff on complex equipment operation and procedures.
• Assisted in preparation of grant applications, including creating summary tables, data collection, and
writing abbreviated protocols and bibliography.
University of Pittsburgh, Pittsburgh, Pennsylvania
Department of Neurology, David Fink, MD. & Marina Mata, MD., Principal Investigators
Research Specialist II 2002 to
2004
Responsible for advancing Parkinson’s disease project. Maximized lab performance through organization,
equipment testing and procedure development. Supervised and trained work-study students effectively on
laboratory techniques.
Research Assistant 1999 to 2002
Worked with a PhD to learn specific techniques and performed research to assist his studies.
COMPUTER SKILLS
Proficient with Word, Excel, Access, Power Point, Photoshop, Illustrator, Prism, LabChart and many others.
EDUCATION
Bachelor of Science, Molecular Biology – University of Pittsburgh (Pittsburgh, PA 2002)
PROFESSIONAL MEMBERSHIPS
• Society for Neuroscience
• International Association for the Study of Pain (IASP)
• American Society for Gene Therapy

3. Veljko Puskovic Page 4
(215) 906-7119  vpuskovic@hotmail.com
PEER-REEVIEWED PUBLICATIONS
• Golder FJ1
, Dax S, Baby SM, Gruber R, Hoshi T, Ideo C, Kennedy A, Peng S, Puskovic V, Ritchie D,
Woodward R, Wardle RL, Van Scott MR, Mannion JC, MacIntyre DE.
Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator.
Anesthesiology. 2015 Sep 9. [Epub ahead of print)
• May WJ, Gruber RB, Discala JF, Puskovic V, Henderson F, Palmer LA, Lewis SJ.
Morphine has latent deleterious effects on the ventilatory responses to a hypoxic challenge.
Open J Mol Integr Physiol. 2013 Nov;3(4):166-180.
• Henderson F, May WJ, Gruber RB, Discala JF, Puskovic V, Young AP, Baby SM, Lewis SJ.
Role of central and peripheral opiate receptors in the effects of fentanyl on analgesia, ventilation and
arterial blood-gas chemistry in conscious rats.
Respir Physiol Neurobiol. 2014 Jan 15;191:95-105.
• Veljko Puskovic 1*
, Jeff Collins 1
, Joseph C. Glorioso 2
, David J. Fink 1
and Marina Mata 1
HSV-mediated delivery of erythropoietin restores striatal function in MPTP treated mice.
Molecular TherapyMol Ther. 2006 Nov;14(5):710-5. Epub 2006 Sep 1.
• Puskovic V, Wolfe D, Goss J, Huang S, Mata M, Glorioso JC, and Fink DJ.
Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Molecular
Therapy 2004 Jul;10(1):67-75.
• Natsume A, Wolfe D, Hu J, Huang S, Puskovic V, Glorioso JC, Fink DJ, Mata M
Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer. Exp
Neurol. 2003 Dec;184(2):878-86.
ABSTRACTS
• Enantiomeric Separation Of Doxapram Reveals The (+)-Enantiomer (GAL-054) To Be A Superior
Respiratory Stimulant With An Improved Therapeutic Index
Francis J. Golder, Santhosh M. Baby, Ryan B. Gruber, Velkjo Puskovic, Scott L. Dax, Sean Peng, Euan
MacIntyre, James C. Mannion
Abstracts.A3616 Conference: American Thoracic Society 2012 International Conference, May 18-23, 2012
• San Francisco, California
• GAL-021, a novel respiratory stimulant, attenuates opioid–induced respiratory depression without
compromising analgesia .
Santhosh M Baby, Ryan B Gruber, VeljkoPuskovic, Sean Peng, Scott L Dax, Francis J Golder, D Euan
MacIntyre and James C Mannion
Galleon Pharmaceuticals
FASEB J. April 2012 26 (Meeting Abstract Supplement) 704.28
• Role of peroxynitrite in postoperative pain.
*V. PUSKOVIC, C. IDEO, R. WOODWARD
Galleon Pharmaceuticals
Annual Meetings/Neuroscience 2011 Abstracts
• Responsiveness Is NotRequired in the Pathogenesis of Inflammatory Demyelinationin the Central Nervous
System
Hongmei Li, Guangxian Zhang, Denise C. Fitzgerald, Veljko Puskovic and Abdolmohamad Rostami

4. Veljko Puskovic Page 4
(215) 906-7119  vpuskovic@hotmail.com
Neurology, University of Thomas Jefferson, Philadelphia, PA
FASEB J. April 2008 22 (Meeting Abstract Supplement) 472
• DEVELOPMENTAL AND FUNCTIONAL CHARACTERIZATION OF IL-17A-PRODUCING CD8+
T
CELLS.
Bogoljub Ciric1
, Mohamed El behi1
, Veljko Puskovic1
, Abdolmohamad Rostami1
.
1
Department of Neurology, Thomas Jefferson University, Philadelphia, PA USA
15th Annual Meeting of the International Cytokine Society